Source usp metronidazole powder for oral use, injections, and prevention

Strategic Sourcing Guide for USP-Grade Metronidazole Powder

The global pharmaceutical supply chain relies heavily on the consistent availability of high-purity active pharmaceutical ingredients (APIs), with metronidazole standing as a cornerstone compound in the treatment of various bacterial and parasitic infections. For procurement professionals seeking USP-grade metronidazole powder, the sourcing process demands a rigorous understanding of technical specifications, regulatory compliance, and supply chain logistics. This guide provides a structured approach to evaluating potential suppliers and ensuring the acquisition of materials that meet stringent quality standards without relying on unverified claims or speculative market data.

Technical Specifications and Product Attributes

When sourcing metronidazole powder, the primary focus must be on aligning the product's physical and chemical attributes with the specific requirements of your manufacturing process. The supplied product data indicates that metronidazole is available in various forms, including powder, tablets, and liquid infusions, with specific models ranging from 200mg tablets to 0.5% infusions. For the specific keyword of "metronidazole powder," buyers must verify that the product is indeed in a solid state, as the data explicitly lists "Powder: Yes" and "State: Solid" for certain listings, while noting "State: Liquid" for infusion products.

The purity of the API is a critical technical parameter. The observed data suggests a purity level of greater than 99% for specific powder variants, which serves as a baseline expectation for high-grade materials. However, buyers should not assume this figure applies universally to all listings without verification. The standard specifications observed include 99% as a reference point, but the exact assay value must be confirmed against the Certificate of Analysis (CoA) provided by the supplier. Furthermore, the product model identifiers such as "Metronidazole" and "200mg" indicate that the material may be sold in specific dosage forms or as a raw API. Procurement teams must distinguish between raw powder intended for compounding and finished dosage forms, as the processing requirements differ significantly.

Packaging standards also vary within the market. The data reflects options such as 100g/bag, 1kg/bag, and 25kg/drum. The choice of packaging impacts storage stability and handling efficiency. For large-scale industrial applications, the 25kg/drum format is often preferred for bulk processing, whereas smaller batches may utilize 1kg or 100g bags. The storage method is explicitly noted as "Moisture Proof," which is a non-negotiable requirement for maintaining the chemical integrity of metronidazole powder, as moisture can degrade the compound and affect its efficacy.

Regulatory Compliance and Certification Verification

Navigating the regulatory landscape is essential for sourcing pharmaceutical-grade materials. The observed product data lists certifications including BP (British Pharmacopoeia), USP (United States Pharmacopeia), and ISO GMP (Good Manufacturing Practice). These certifications are critical indicators of a supplier's adherence to international quality standards. However, buyers must treat these as observed attributes of specific listings rather than universal guarantees for all metronidazole powder available in the market.

The USP standard is particularly relevant for buyers targeting the North American market or those requiring compliance with United States Pharmacopeia monographs. The presence of "BP" and "USP" in the certification list suggests that some suppliers may offer materials compliant with these specific pharmacopoeias. Nevertheless, the verification process must involve direct confirmation of the current certification status. Buyers should request valid, up-to-date certification documents and verify their authenticity with the issuing bodies. Relying on a supplier's self-declared status without independent verification introduces significant compliance risk.

Additionally, the production line status is noted as "GMP Approved" in the provided data. This indicates that the manufacturing facility adheres to Good Manufacturing Practice guidelines, which is a prerequisite for producing pharmaceutical ingredients. Buyers should ensure that the GMP certification covers the specific product line and manufacturing site associated with the metronidazole powder being purchased. The location of production, observed as "China" and specifically "Hebei," provides context for the supply chain but does not inherently dictate quality. Buyers must evaluate the regulatory oversight of the specific region and the facility's history of compliance with local and international regulations.

Cost Drivers and Pricing Dynamics

The pricing of metronidazole powder is influenced by a complex interplay of factors, including raw material costs, manufacturing complexity, packaging requirements, and regulatory compliance overhead. The observed price range in the market spans from 0.01 to 300 USD, reflecting a wide spectrum of product types, from small sample quantities to bulk industrial shipments. This broad range underscores the importance of defining the exact procurement requirements before engaging with suppliers.

The minimum order quantity (MOQ) is another significant cost driver. The observed MOQ range extends from 1 to 100,000 units, indicating that suppliers cater to both small-scale researchers and large-scale pharmaceutical manufacturers. For buyers seeking bulk quantities, negotiating a lower unit price is often possible, but this must be balanced against inventory holding costs and storage capabilities. The packaging format also influences cost; larger drums typically offer a lower cost per kilogram compared to smaller bags, but they require specialized handling equipment.

Buyers should be cautious of price points that seem abnormally low, as they may indicate compromised quality or non-compliant products. The data suggests that high-purity products with certifications like USP and ISO GMP command a premium. Therefore, the cost should be evaluated in the context of the total value proposition, including quality assurance, regulatory support, and supply chain reliability. It is essential to obtain detailed quotations that break down costs by material, packaging, and logistics to ensure transparency and avoid hidden fees.

Typical Applications and Usage Modes

Metronidazole powder is a versatile API with a wide range of applications in the pharmaceutical industry. The observed data highlights its use in "Infectious Disease Prevention Medicine" and "Parasite Disease Prevention Medicine," reflecting its primary role in treating anaerobic bacterial infections and parasitic diseases such as giardiasis and trichomoniasis. The product is categorized under "Chemical Synthetic Drugs," indicating that it is produced through chemical synthesis rather than biological extraction.

The usage mode is specified as "For oral administration," which aligns with its common formulation in tablets and capsules. However, the data also mentions "Internal Medicine" and "Oral Preparation," suggesting its application in various dosage forms. For buyers sourcing the powder, it is crucial to understand the intended end-use, as this dictates the required purity and particle size specifications. The powder may be used for compounding in pharmacies, manufacturing in pharmaceutical plants, or as an intermediate in the production of other drug formulations.

The data also notes that the product is suitable for "Adult, Children, and Elderly," indicating its broad applicability across different patient demographics. This versatility makes metronidazole a high-demand product, but it also requires strict quality control to ensure safety across all age groups. Buyers should verify that the powder meets the specific purity and impurity limits required for pediatric and geriatric formulations, as these populations may have different sensitivity profiles.

Supplier Evaluation and Selection Criteria

Selecting the right supplier is a critical step in the procurement process. The evaluation should go beyond price and focus on the supplier's ability to consistently deliver high-quality products that meet regulatory requirements. Key criteria include the supplier's certification status, production capacity, quality control systems, and track record. The observed data lists "GMP Approved" production lines and certifications like "BP, USP, ISO GMP," which are strong indicators of a supplier's commitment to quality.

Buyers should conduct a thorough due diligence process, including site audits and review of past performance. The location of the supplier, observed as "China" and "Hebei," should be considered in the context of logistics and regulatory oversight. While the region is a major hub for pharmaceutical manufacturing, buyers must ensure that the specific facility has a robust quality management system. The ability to provide detailed documentation, including batch-specific CoAs and stability data, is a key differentiator between reliable and unreliable suppliers.

Customization capabilities are another factor to consider. The data indicates that "Customization: Available" and "Customized: Non-Customized" are both observed attributes, suggesting that some suppliers offer tailored solutions while others provide standard products. Buyers should clarify their specific needs regarding packaging, labeling, and documentation to ensure alignment with the supplier's capabilities. The "Pharmaceutical Technology: Chemical Synthesis" process is standard for metronidazole, but buyers should verify the specific synthesis method and any proprietary processes that may affect product quality.

Quality Control and Long-Term Procurement Considerations

Maintaining product quality throughout the supply chain is essential for the safety and efficacy of pharmaceutical products. The observed "Storage Method: Moisture Proof" highlights the importance of proper storage conditions. Buyers must ensure that their own storage facilities and those of their logistics partners are capable of maintaining the required environmental conditions. The "State: Solid" and "Powder: Yes" attributes emphasize the need for careful handling to prevent contamination or degradation.

Long-term procurement considerations include supply chain resilience and the ability to scale production. The observed MOQ range of 1 to 100,000 units suggests that suppliers can accommodate varying demand levels, but buyers should assess the supplier's capacity to handle sudden increases in order volume. Lead times and production schedules should be clearly defined in the contract to avoid disruptions. The "Production Line: GMP Approved" status provides a foundation for reliability, but buyers should also evaluate the supplier's contingency plans for potential disruptions.

Quality control should be an ongoing process, not a one-time event. Buyers should establish clear protocols for incoming quality inspection, including verification of purity, identity, and assay results. The "Purity: >99%" observation serves as a benchmark, but buyers must define their own acceptance criteria based on their specific application requirements. Regular audits and performance reviews of suppliers are necessary to ensure continued compliance and quality.

Comparative Analysis of Product Variants

To facilitate informed decision-making, the following table summarizes key attributes of the observed metronidazole product variants. This comparison highlights the diversity in specifications, packaging, and certifications available in the market.

This table illustrates that while the core active ingredient remains the same, the physical form and packaging vary significantly based on the intended application. Buyers must carefully select the variant that aligns with their manufacturing needs and regulatory requirements. The presence of USP and ISO GMP certifications in the powder variant underscores its suitability for high-quality pharmaceutical production, whereas the infusion and tablet variants may have different regulatory pathways.

In conclusion, sourcing USP-grade metronidazole powder requires a meticulous approach that balances technical specifications, regulatory compliance, and supply chain reliability. By adhering to the guidelines outlined in this guide, procurement professionals can mitigate risks and ensure the acquisition of high-quality materials that meet the stringent demands of the pharmaceutical industry.